GroYourBiz Honours Canadian Clinical Leaders as “Champions of Change”

Jun 22, 2026 | News

Image Source: GroYourBiz
Press Release
Written by: Press Release
On behalf of: GroYourBiz

GroYourBiz (GYB), a leading organisation supporting female senior leaders and women-owned businesses, is proud to announce the recipients of its 2026 Champion of Change Award, three exceptional clinical leaders whose innovation and determination are transforming patient care in Canadian hospitals and influencing healthcare practices internationally.

The 2026 honourees are:

  • Professor Stephanie Smith, Professor in the Division of Infectious Diseases at the University of Alberta and Director of Hospital Infection Prevention and Control at the University of Alberta Hospital / Mazankowski Alberta Heart Institute
  • Dr. Claudia Malic, Plastic Surgeon at The Ottawa Hospital and Associate Professor at the University of Ottawa’s Faculty of Medicine
  • Kate Duke, RN, Director of Perioperative Services and Surgical Care at The Ottawa Hospital

Professor Smith received her award at a GroYourBiz event in Calgary, while Dr. Malic and Ms. Duke were recognised in Ottawa during The Ottawa Hospital’s recent Collins Day celebration.

Jeremy Kerr (Director of Sales at Ondine Biomedical) and Professor. Stephanie Smith (Champion of Change Award recipient)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

These accomplished healthcare leaders were nominated by Ondine Biomedical Inc. in recognition of their courage and leadership in advancing innovative infection-prevention protocols within their institutions. Their work has generated significant improvements in patient care, contributed meaningful clinical data, and helped shape best practices beyond their own hospitals.

Driving Measurable Change in Patient Outcomes

The Champion of Change Award recognises women who challenge convention, lead with evidence, and create lasting impact in complex environments. This year’s recipients exemplify that spirit.

At the Mazankowski Alberta Heart Institute, Professor Stephanie Smith championed the replacement of a traditional five-day pre-surgical antibiotic treatment with a novel five-minute light-based nasal treatment (Steriwave®) designed to eliminate infection-causing germs from the nose before surgery. The change resulted in a 32% reduction in infections following cardiac surgery. Her leadership has helped reduce reliance on antibiotics while improving patient safety and lowering costs.

At The Ottawa Hospital, Dr. Claudia Malic and Kate Duke championed the integration of the same innovative infection-prevention protocol, resulting in patients’ length of stay and readmission rates decreasing by approximately half, alongside substantial decreases in antibiotic use and emergency room visits. Their collaborative leadership has positioned their hospital as a model for evidence-driven surgical infection prevention.

The clinical data generated through their efforts has not only improved patient outcomes locally but has also sparked broader interest across Canada and internationally, encouraging other healthcare institutions to explore similar approaches.

Recognising Leadership That Inspires Systemic Change

“Champions of Change are women who see an opportunity to improve outcomes and take decisive action even in the face of entrenched systems,” said Barbara Mowat, President of GroYourBiz. “Professor Smith, Dr. Malic, and Kate Duke exemplify the kind of leadership that transforms institutions and sets new standards for patient care. Progress depends on leaders who are willing to recognise and act on sound solutions early, creating the evidence and pathway others will follow.”

Carolyn Cross, Founder and CEO of Ondine Biomedical, added:

“We are deeply grateful for the leadership, rigour and courage these remarkable women brought to advancing new infection-prevention protocols within their hospitals. Their commitment to improving patient safety has not only strengthened care at their own hospitals but also generated important clinical data that is helping inform healthcare systems in Canada and abroad. We are thrilled to see Professor Smith, Dr. Malic and Kate Duke recognised as true Champions of Change.”

A Broader Impact

By embracing innovation and rigorously measuring outcomes, these honourees have helped elevate the national conversation around antimicrobial resistance, surgical site infection prevention, and the importance of clinical leadership. Their work continues to open doors for collaboration, research, and improved patient care across healthcare systems.

About GroYourBiz (GYB)

GroYourBiz is a leadership and business-growth advisory organisation for women business owners and senior women business leaders across Canada and internationally. Its members are presidents, owners, and executives committed to exceeding performance expectations and building resilient enterprises.

Through its Champion of Change initiative, GYB recognises influential women whose leadership and vision drive transformative progress across industries, including healthcare. Under the guidance of Barbara Mowat, GYB serves as a catalyst for growth, impact, and positive change across Canada and internationally.

Contact: Barbara Mowat, President (barbara.mowat@groyourbiz.com)

 

Feature image: Barbara Mowat (President of GroYourBiz), Carolyn Cross (CEO of Ondine Biomedical), Dr. Claudia Malic and Kate Duke (Champion of Change Award recipients)

    References: None included.
    This is a company announcement published as received.  The content has not been independently verified by Life Science Daily News.

    Articles that may be of interest

    Weekly News Roundup | 22 June 2026

    Weekly News Roundup | 22 June 2026

    Life science news 22 June 2026: the FDA clears the first disease-modifying therapy for newly diagnosed childhood type 1 diabetes, the MHRA approves the UK's first cancer treatment delivered by on-body injector, and GSK wins approval for the first oral carbapenem...

    read more
    Weekly News Roundup | 15 June 2026

    Weekly News Roundup | 15 June 2026

    Life science news 15 June 2026: GSK's $10.6 billion Nuvalent acquisition headlines a blockbuster M&A week, the MHRA approves the UK's first oral weight-loss semaglutide tablet, and the FDA clears a new adjuvant combination for kidney cancer in a landmark week for...

    read more
    Weekly News Roundup | 8 June 2026

    Weekly News Roundup | 8 June 2026

    Life science news 8 June 2026: ASCO delivers landmark oncology data, GSK achieves hepatitis B functional cure breakthrough, and Servier secures a $2.65 billion rare disease deal in a milestone week for the industry. Revolution Medicines presented full Phase 3 data for...

    read more

    Articles that may be of interest

    Weekly News Roundup | 22 June 2026

    Weekly News Roundup | 22 June 2026

    Life science news 22 June 2026: the FDA clears the first disease-modifying therapy for newly diagnosed childhood type 1 diabetes, the MHRA approves the UK's first cancer treatment delivered by on-body injector, and GSK wins approval for the first oral carbapenem...

    read more
    Weekly News Roundup | 15 June 2026

    Weekly News Roundup | 15 June 2026

    Life science news 15 June 2026: GSK's $10.6 billion Nuvalent acquisition headlines a blockbuster M&A week, the MHRA approves the UK's first oral weight-loss semaglutide tablet, and the FDA clears a new adjuvant combination for kidney cancer in a landmark week for...

    read more
    Weekly News Roundup | 8 June 2026

    Weekly News Roundup | 8 June 2026

    Life science news 8 June 2026: ASCO delivers landmark oncology data, GSK achieves hepatitis B functional cure breakthrough, and Servier secures a $2.65 billion rare disease deal in a milestone week for the industry. Revolution Medicines presented full Phase 3 data for...

    read more